Exodus Point Capital Management, LP Halozyme Therapeutics, Inc. Transaction History

Exodus Point Capital Management, LP

$16.4 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$36.46 - $44.03 $10.5 Million - $12.7 Million	-287,405 Reduced 84.54%	52,558 $2.01 Million
Q2 2023 Aug 10, 2023	BUY	$30.28 - $38.74 $5.64 Million - $7.21 Million	186,111 Added 120.97%	339,963 $12.3 Million
Q1 2023 May 11, 2023	BUY	$32.86 - $55.7 $1.86 Million - $3.15 Million	56,604 Added 58.21%	153,852 $5.88 Million
Q4 2022 Feb 13, 2023	SELL	$40.06 - $59.44 $69,504 - $103,128	-1,735 Reduced 1.75%	97,248 $5.53 Million
Q3 2022 Nov 10, 2022	SELL	$38.53 - $51.78 $2.36 Million - $3.17 Million	-61,296 Reduced 38.24%	98,983 $3.91 Million
Q2 2022 Aug 19, 2022	BUY	$37.35 - $48.3 $1.21 Million - $1.57 Million	32,411 Added 25.35%	160,279 $7.05 Million
Q1 2022 May 13, 2022	BUY	$31.97 - $41.06 $2.32 Million - $2.98 Million	72,636 Added 131.51%	127,868 $5.1 Million
Q4 2021 Feb 11, 2022	BUY	$31.82 - $40.75 $1.76 Million - $2.25 Million	55,232 New	55,232 $2.22 Million
Q2 2021 Aug 16, 2021	SELL	$38.84 - $51.31 $1.25 Million - $1.65 Million	-32,161 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$39.51 - $51.45 $1.27 Million - $1.65 Million	32,161 New	32,161 $1.34 Million
Q4 2020 Feb 16, 2021	SELL	$25.81 - $43.62 $1.33 Million - $2.25 Million	-51,617 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$25.74 - $29.63 $78,609 - $90,490	3,054 Added 6.29%	51,617 $1.36 Million
Q2 2020 Aug 14, 2020	BUY	$16.25 - $26.81 $789,148 - $1.3 Million	48,563 New	48,563 $1.3 Million
Q1 2020 May 15, 2020	SELL	$13.9 - $21.83 $375,744 - $590,108	-27,032 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$14.93 - $19.53 $403,587 - $527,934	27,032 New	27,032 $479,000

Others Institutions Holding HALO

# of Institutions

542

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

Black Rock Inc. New York, NY

17.6M
Shares

$930 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

12.9M
Shares

$681 Million
0.01% of portfolio
State Street Corp Boston, MA

6.63M
Shares

$350 Million
0.02% of portfolio
Snyder Capital Management L P San Francisco, CA

4.06M
Shares

$215 Million
5.07% of portfolio
Alliancebernstein L.P. New York, NY

3.41M
Shares

$180 Million
0.07% of portfolio

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.35B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Account